CJ Bioscience Logo

CJ Bioscience

Develops microbiome therapeutics for oncology & IBD using an AI drug discovery platform.

311690 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 중구 세종대로 14 그랜드센트럴타워 B동 7층, 중구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

CJ Bioscience, Inc. is a biopharmaceutical company focused on developing next-generation, microbiome-based therapeutics. Leveraging its proprietary AI-powered drug discovery platform, Ez-Mx®, the company analyzes the relationship between human microbiomes and disease to address unmet medical needs. Its therapeutic programs are concentrated on oncology and inflammatory bowel disease (IBD), with a pipeline of live biotherapeutic products. CJ Bioscience aims to create innovative treatments, such as orally administered drugs, designed to offer improved safety and convenience compared to existing therapies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-28 00:00
Regulatory News Service
대규모기업집단현황공시[분기별공시(개별회사용)]
Korean 5.9 KB
2025-08-14 00:00
Regulatory News Service
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
Korean 11.0 KB
2025-08-14 00:00
Post-Annual General Meeting Information
임시주주총회결과
Korean 7.3 KB
2025-08-14 00:00
Board/Management Information
대표이사변경
Korean 10.7 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.4 MB
2025-07-30 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 46.5 KB
2025-07-08 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB
2025-07-08 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 9.0 KB
2025-06-02 00:00
Major Shareholding Notification
대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
Korean 81.9 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.1 MB
2025-03-26 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 17.4 KB
2025-03-17 00:00
Audit Report / Information
감사보고서제출
Korean 26.0 KB
2025-03-17 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 376.8 KB
2025-03-05 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 166.0 KB
2025-03-04 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 7.4 KB

Automate Your Workflow. Get a real-time feed of all CJ Bioscience filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for CJ Bioscience via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.